source
- Dr Postow on an Ideal Post-ICI Monitoring Framework in MelanomaMichael A. Postow, MD, discusses the importance of long-term multidisciplinary follow-up for patients with melanoma treated with ICIs.onclive · 3mo ago↗ source
- Dr Postow on the Timing of Delayed or Re-Emergent irAEs in MelanomaMichael A. Postow, MD, discusses the evolving understanding of ICIs in melanoma and the unique toxicity profiles associated with these agents.onclive · 3mo ago↗ source
- FDA chief Marty Makary resigns from agency, ending tumultuous tenureMakary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.BioPharma Dive · 3mo ago↗ source